ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Pharma company enabling accurate pill splitting raises $1 million

Featured Story

Pharma company enabling accurate pill splitting raises $1 million

May 24, 2013 7:35 am by | 0 Comments

A Florida company trying to make the practice of pill splitting safer and easier has raised at least $1 million in its latest round of funding.According to a Form D filing, Accu-Break Pharmaceuticals Inc. could continue raising up to $1.5 million in equity, debt and other securities. The company’s vice ... Read more
Steroid linked to last year’s meningitis outbreak may be tainted

Steroid linked to last year’s meningitis outbreak may be tainted

May 24, 2013 2:38 pm by | 0 Comments

(Updates with type of contamination, details, background)May 24 (Reuters) - The U.S. Food and Drug Administration said on Friday it has received seven reports of negative reactions by patients who ... Read more
After failed deal with Actavis, Valeant nearing deal to acquire Bausch & Lomb

After failed deal with Actavis, Valeant nearing deal to acquire Bausch & Lomb

May 24, 2013 12:26 pm by | 0 Comments

NEW YORK (Reuters) - Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch & Lomb Holdings Inc from Warburg Pincus LLC for about $9 billion, ... Read more
Novo rejects analysts doubts, plans to launch obesity drug in U.S.

Novo rejects analysts doubts, plans to launch obesity drug in U.S.

May 24, 2013 6:20 am by | 0 Comments

COPENHAGEN, May 24 (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some ... Read more
Aveo partner Astellas won’t seek EU marketing approval for kidney cancer drug

Aveo partner Astellas won’t seek EU marketing approval for kidney cancer drug

May 23, 2013 5:50 pm by | 0 Comments

(Reuters) - Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be seeking marketing approval for their experimental kidney cancer ... Read more
32 life science and health IT startups will compete in MassChallenge 2013

32 life science and health IT startups will compete in MassChallenge 2013

May 23, 2013 5:08 pm by | 0 Comments

Who will win this year’s MassChallenge? The Boston accelerator is set to get its fourth session underway with the announcement of the 128 new startups that will participate. A quarter ... Read more
“Munchies” aside, pot smokers’ waists smaller than non-users

“Munchies” aside, pot smokers’ waists smaller than non-users

May 23, 2013 3:43 pm by | 0 Comments

NEW YORK (Reuters Health) - People who had used marijuana in the past month had smaller waists and lower levels of insulin resistance - a diabetes precursor - than those ... Read more
Patent rights on coronavirus delay development of diagnostic tests

Patent rights on coronavirus delay development of diagnostic tests

May 23, 2013 2:04 pm by | 0 Comments

GENEVA (Reuters) - The World Health Organization (WHO) warned countries with possible cases of the SARS-like novel coronavirus on Thursday that they must share information and not allow commercial labs ... Read more
Scientists reject dramatic findings on cancer drug in Alzheimer’s mice

Scientists reject dramatic findings on cancer drug in Alzheimer’s mice

May 23, 2013 1:59 pm by | 0 Comments

CHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already approved by U.S. regulators could quickly clear out Alzheimer's plaques in mice was ... Read more
Already a diabetes drug, trial confirms weight loss application

Already a diabetes drug, trial confirms weight loss application

May 23, 2013 12:57 pm by | 0 Comments

COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said Phase III study results had shown people treated with its liraglutide drug had an 8 percent weight loss."These ... Read more
After a restructure and an axed Merck deal, Acumen gains $20M for novel Alzheimer’s drug

After a restructure and an axed Merck deal, Acumen gains $20M for novel Alzheimer’s drug

May 23, 2013 10:29 am by | 0 Comments

It’s been 17 years in the making, but Acumen Pharmaceuticals hasn’t given up hope for its approach to a disease-modifying drug for Alzheimer’s disease. After restructuring to become a virtual ... Read more
BTG’s interventional medicine buys may drive sales to $1 billion

BTG’s interventional medicine buys may drive sales to $1 billion

May 23, 2013 8:07 am by | 0 Comments

LONDON (Reuters) - British pharmaceutical company BTG announced two deals on Thursday that it said could create an interventional medicine business with potential sales of $1 billion.Chief Executive Louise Makin ... Read more
GSK pandemic flu shot may raise narcolepsy risks for adults

GSK pandemic flu shot may raise narcolepsy risks for adults

May 23, 2013 7:13 am by | 0 Comments

HELSINKI/LONDON (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health ... Read more
FDA panel backs a new sleep drug suvorexant at lower dose

FDA panel backs a new sleep drug suvorexant at lower dose

May 23, 2013 6:55 am by | 0 Comments

An advisory panel to the Food & Drug Administration has recommended approval of a new sleep drug that targets the brain's wakefulness centers, but suggested the agency should consider a ... Read more
Pfizer leads race to create MRSA vaccine, but it’s only halfway home

Pfizer leads race to create MRSA vaccine, but it’s only halfway home

May 23, 2013 12:59 am by | 0 Comments

CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped ... Read more
Update on anticoagulation for atrial fibrillation: Encouraging news for rivaroxaban (Xarelto)

Update on anticoagulation for atrial fibrillation: Encouraging news for rivaroxaban (Xarelto)

May 22, 2013 11:29 pm by | 0 Comments

It’s time to do an update on the treatment of atrial fibrillation. It’s been a while, and there are worthy things to report from the real world. Stroke prevention in ... Read more